Aio-studien-ggmbh
Clinical trials sponsored by Aio-studien-ggmbh, explained in plain language.
-
Can adding radiation to osimertinib tame resistant lung cancer?
Disease control OngoingThis phase 2 study tests whether it is safe to continue the targeted drug osimertinib (Tagrisso) while also giving radiation therapy to people with advanced EGFR-positive non-small cell lung cancer that has started to grow in a few spots. About 42 participants will receive both t…
Phase: PHASE2 • Sponsor: AIO-Studien-gGmbH • Aim: Disease control
Last updated Jun 24, 2026 03:05 UTC
-
Could a painkiller boost chemo for tough colorectal cancers?
Disease control OngoingThis early-stage trial tests whether adding D,L-methadone (a pain medication) to standard chemotherapy (mFOLFOX6) can help control advanced colorectal cancer that has stopped responding to other treatments. The study involves 11 participants and aims to find the safest dose and m…
Phase: PHASE1, PHASE2 • Sponsor: AIO-Studien-gGmbH • Aim: Disease control
Last updated Jun 11, 2026 12:11 UTC